san021
Botanicalexperimental
Clinical trial activity
2 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2017 (NCT03000608)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- san021
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02993328 | Phase 2 | Jun 1, 2017 | ClinDatrix, Inc., Fremantle Dermatology, Santalis Pharmaceuticals |
| NCT03000608 | Phase 2 | May 1, 2017 | ClinDatrix, Inc., Clinical Trials of Texas, Inc, Dermatology Clinical Research Center of San Antonio, Derm Research Incorporated, Santalis Pharmaceuticals |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ClinDatrix, Inc. | For profit | 2 | 0 | 1 | 2017 |
| Santalis Pharmaceuticals | For profit | 2 | 2 | 1 | 2017 |
| Clinical Trials of Texas, Inc | For profit | 1 | 0 | 1 | 2017 |
| Dermatology Clinical Research Center of San Antonio | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Derm Research Incorporated | For profit | 1 | 0 | 1 | 2017 |
| Fremantle Dermatology | Academic/Hospital | 1 | 0 | 1 | 2017 |
6 organizations
Page 1 / 1